Heather Raymon

Insider Reports History

Location
San Diego, CA
Signature
/s/ Andrew Cronauer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heather Raymon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Artiva Biotherapeutics, Inc. SVP, Research and Development Common Stock 151,323 $605,292 $4.00 15 Feb 2026 Direct
Artiva Biotherapeutics, Inc. SVP, Research and Development Employee Stock Option (Right to Buy) 0 12 Dec 2025 Direct

Insider Reports Filed by Heather Raymon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARTV Artiva Biotherapeutics, Inc. 15 Feb 2026 2 -$6,084 4 SVP, Research and Development 18 Feb 2026, 18:51
ARTV Artiva Biotherapeutics, Inc. 12 Dec 2025 6 $0 4 SVP, Research and Development 12 Dec 2025, 19:21
ARTV Artiva Biotherapeutics, Inc. 15 Nov 2025 1 -$4,469 4 SVP, Research and Development 17 Nov 2025, 20:39
ARTV Artiva Biotherapeutics, Inc. 15 May 2025 2 -$6,094 4 SVP, Research and Development 18 Aug 2025, 20:15
ARTV Artiva Biotherapeutics, Inc. 26 Feb 2025 1 $0 4 SVP, Research and Development 28 Feb 2025, 17:15
ARTV Artiva Biotherapeutics, Inc. 12 Sep 2024 1 $0 4 SVP, Research and Development 13 Sep 2024, 16:15
ARTV Artiva Biotherapeutics, Inc. 18 Jul 2024 0 $0 3 SVP, Research and Development 18 Jul 2024, 20:02